Please assess the completion status of the following clinical trial:

Trial Title: Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~ICU patients with a diagnosis of documented candidemia or invasive candidiasis and belonging to one or more of the following specific populations:~* Post-abdominal surgery.~* Elderly \> 65 years old.~* Renal insufficiency / failure / hemodialysis.~* Solid tumor.~* Solid-organ (liver, kidney, lung, heart) transplant recipients.~* Hepatic insufficiency.~* Neutropenic including hematology oncology patients.~Exclusion Criteria:~Patients with poor venous access that would preclude IV drug delivery or multiple blood draws.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): Option to treat with oral azole therapy following treatment with anidulafungin

Based on this trial design, predict the completion outcome and termination type (if applicable).